What's breaking now, across thousands of outlets.
Plus news about Sino Biopharm and AtomVie. Yarrow gets more money: New Haven-based Yarrow Bioscience priced a $150 million offering at $26 per share {$YARW}, about $2.50 below its Thursday closing ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Thane, September 11, 2026: A 39-year-old man with Marfan syndrome underwent a complex heart surgery after doctors found that the aortic root, the part of the main blood vessel closest to the heart…
A trade group representing generics and biosimilars is warning that the lack of product development could imperil billions of dollars in potential savings.
RA Capital has already participated in four biotech financings in September. Meanwhile, Janus Henderson has been the year's most prolific backer of biotech reverse merger deals, according to Gilmartin…
The Centers for Disease Control and Prevention declared the Cyclospora outbreak related to Taylor Farms lettuce over Friday, though the Food and Drug Administration says its investigation remains…
The worst U.S. measles outbreak in decades is growing and flu season is imminent. Experts are fretting about federal health data reliability after the CDC questioned two Pennsylvania measles deaths.
The worst U.S. measles outbreak in decades is growing and flu season is imminent. Experts are fretting about federal health data reliability after the CDC questioned two Pennsylvania measles deaths.
